Impax Laboratories Inc. (IPXL)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q4 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 12.83% | 833,500 | 0.18 | |
| Q2 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Add 6705.45% | 7,054,136 | 1.43 | |
| Q1 2017 | |||||
| ≡ | Lee Ainslie - Maverick Capital | Buy | 105,200 | 0.02 | |
| Q1 2016 | |||||
| ≡ | Meridian Contrarian Fund | Add 5.59% | 8,185 | 0.05 | |
| Q1 2015 | |||||
| ≡ | Meridian Contrarian Fund | Add 15.05% | 35,000 | 0.25 | |
| Q2 2014 | |||||
| ≡ | Meridian Contrarian Fund | Add 54.49% | 82,000 | 0.35 | |
| Q1 2014 | |||||
| ≡ | Meridian Contrarian Fund | Buy | 150,500 | 0.55 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.